Intended for healthcare professionals


Four in one polypill halves predicted cardiovascular risk, international study shows

BMJ 2011; 342 doi: (Published 27 May 2011) Cite this as: BMJ 2011;342:d3355

A Long Awaited Bullet Against Cardiovascular Diseases.

Combination therapy seems to be the immediate pharmacological future,
at our hands, in the war against common, complex, and progressive diseases
like the major cardiovascular diseases.

Small doses of individual medications incorporated on a single pill
sounds like magic to enhance adherence and compliance with chronic

I really think, that for clinicians, prospective, large, randomized
trials are urgently needed, in order to get this good concept into
clinical practice without any fears.

And we will be waiting for them, with the best hope.

Competing interests: No competing interests

28 May 2011
Jose Mario Franco de Oliveira
Associate Professor of Medicine
Department of Medicine - Universidade Federal Fluminense.